沉痛悼念!扬子江药业董事长徐镜人逝世,享年77岁!

2021-07-11 网络 网络

扬子江药业——董事长、

扬子江药业——董事长、中国医药的一代骄子,徐镜人先生因病逝世,享年77岁!沉痛悼念!

图片

“他的家人告知了我此消息,徐镜人在伊犁开会期间突发心梗离世。”一位与徐镜人是江苏泰州同乡的医生说。

图片

 

徐镜人,男,江苏泰州人,1944年10月出生,大专学历,高级经济师,中共党员,全国人大代表,江苏省商会副会长,首届江苏省优秀创业企业家。1971年一手创立扬子江药业集团。扬子江药业集团是科技部命名的全国首批创新型企业,2014年-2019年,连续6年位居中国医药工业企业百强榜第1名,目前有员工16000余人。

扬子江药业集团党委书记、董事长兼总经理。

2018年12月7日,被江苏省公示为“改革开放40年先进个人”。

2019年福布斯全球亿万富豪榜排名第394位,财富值47亿美元。

2019年10月10日,《2019年胡润百富榜》揭晓,徐镜人以430亿元人民币财富获得62名。 

2020年2月26日,以480亿元人民币财富名列《2020世茂深港国际中心·胡润全球富豪榜》第311位。

扬子江药业,靠板蓝根发家,这也是一家奇怪的企业,年销售额高达800亿,其创始人徐镜人却始终反对上市,是中国当之无愧的“药王。

2020年最新的福布斯富豪榜显示,徐镜人目前个人身家为32亿美元,位列中国医疗富豪榜第23名。

徐镜人可以称之一代枭雄,中国制药史里程碑的人物之一。

扬子江的发展史

1971年,26岁的徐镜人辞掉了家乡的“铁饭碗”,准备了几千元的创业资金,拉上几个老乡,开始了自己的创业之路。他租了一块空地,盖起了六间平房当作生产车间,并且再添置了几只大缸和简陋的设备,医药加工厂就创建了。徐镜人也前往安阳制药厂学习后苦心钻研,研发出了板蓝根颗粒。

1985年,药厂更名为扬子江制药厂。1988年对扬子江药业而言是至关重要的一年,当时上海爆发了引起全国恐慌的甲型肝炎,形势非常严峻,治疗药物主要就是板蓝根干糖浆。市面上的板蓝根被一抢而空、供不应求。由于扬子江药业的板蓝根质量好,根据主管部门的安排,扬子江制药厂要负责生产四百万包药物进行支援。

当时厂里产能上限很难保证供应,徐镜人亲自带着工人加班加点,在两个月内生产了385万袋板蓝根,解了上海的燃眉之急。

就在这一年,扬子江药业的产值突破亿元。

徐镜人对产品质量的高要求让扬子江药业抓住机遇获得了起飞机会,之后的多年里,他也在各种场合下反复强调集团对质量的精益求精。

“要时刻谨记没有质量的产品,不是产品,没有质量的生产,不是生产。”7月7日,经济参考报发布的《扬子江药业集团董事长徐镜人:质量是企业品牌的灵魂》一文,这或许是徐镜人最后一次接受媒体采访,他依旧强调,质量是企业品牌的灵魂,没有质量,企业也就无法生存。

2018年,扬子江药业年营收入突破800亿,2019年,扬子江药业集团实现销售、利税同比分别增长11.94%和16.2%。2020年发布的国内药企营收榜单数据显示,扬子江营收已经超过千亿。

2014年~2019年,扬子江连续6年位居中国医药工业企业百强榜第1名,以传统中药制造起家,其产品“蓝芩口服液”“苏黄止咳胶囊”等产品市场占有额、品牌知名度较高。

沉痛哀悼徐镜人先生!

图片

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1969196, encodeId=75c1196919663, content=<a href='/topic/show?id=af99882909c' target=_blank style='color:#2F92EE;'>#董事长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88290, encryptionId=af99882909c, topicName=董事长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Jan 24 12:41:06 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495321, encodeId=bf2c1495321c7, content=<a href='/topic/show?id=2b045310288' target=_blank style='color:#2F92EE;'>#悼念#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53102, encryptionId=2b045310288, topicName=悼念)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7da9165163, createdName=zhangfenasdf, createdTime=Tue Jul 13 10:41:06 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998758, encodeId=60ec998e582c, content=悼念, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201208/af76c3dece7248f2b297751d57470291/d45c15338e034c3f847da0bca70bfa4d.jpg, createdBy=3cfe1656094, createdName=cscs, createdTime=Mon Jul 12 11:39:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998748, encodeId=44f1998e48e0, content=🙏🙏🙏, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Mon Jul 12 11:24:18 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998588, encodeId=5ec89985885e, content=悼念, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9c5544669, createdName=Amy啊, createdTime=Sun Jul 11 20:59:23 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998576, encodeId=9b009985e622, content=一代豪杰!如此年龄,仍然在一线工作,这几年准备将事业逐步交给儿子和女儿!企业家真心不易呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 11 20:07:34 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998577, encodeId=c74c9985e74f, content=医药领域一周大事频发,扬子江,恒瑞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 11 20:07:44 CST 2021, time=2021-07-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1969196, encodeId=75c1196919663, content=<a href='/topic/show?id=af99882909c' target=_blank style='color:#2F92EE;'>#董事长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88290, encryptionId=af99882909c, topicName=董事长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Jan 24 12:41:06 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495321, encodeId=bf2c1495321c7, content=<a href='/topic/show?id=2b045310288' target=_blank style='color:#2F92EE;'>#悼念#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53102, encryptionId=2b045310288, topicName=悼念)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7da9165163, createdName=zhangfenasdf, createdTime=Tue Jul 13 10:41:06 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998758, encodeId=60ec998e582c, content=悼念, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201208/af76c3dece7248f2b297751d57470291/d45c15338e034c3f847da0bca70bfa4d.jpg, createdBy=3cfe1656094, createdName=cscs, createdTime=Mon Jul 12 11:39:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998748, encodeId=44f1998e48e0, content=🙏🙏🙏, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Mon Jul 12 11:24:18 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998588, encodeId=5ec89985885e, content=悼念, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9c5544669, createdName=Amy啊, createdTime=Sun Jul 11 20:59:23 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998576, encodeId=9b009985e622, content=一代豪杰!如此年龄,仍然在一线工作,这几年准备将事业逐步交给儿子和女儿!企业家真心不易呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 11 20:07:34 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998577, encodeId=c74c9985e74f, content=医药领域一周大事频发,扬子江,恒瑞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 11 20:07:44 CST 2021, time=2021-07-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1969196, encodeId=75c1196919663, content=<a href='/topic/show?id=af99882909c' target=_blank style='color:#2F92EE;'>#董事长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88290, encryptionId=af99882909c, topicName=董事长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Jan 24 12:41:06 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495321, encodeId=bf2c1495321c7, content=<a href='/topic/show?id=2b045310288' target=_blank style='color:#2F92EE;'>#悼念#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53102, encryptionId=2b045310288, topicName=悼念)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7da9165163, createdName=zhangfenasdf, createdTime=Tue Jul 13 10:41:06 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998758, encodeId=60ec998e582c, content=悼念, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201208/af76c3dece7248f2b297751d57470291/d45c15338e034c3f847da0bca70bfa4d.jpg, createdBy=3cfe1656094, createdName=cscs, createdTime=Mon Jul 12 11:39:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998748, encodeId=44f1998e48e0, content=🙏🙏🙏, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Mon Jul 12 11:24:18 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998588, encodeId=5ec89985885e, content=悼念, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9c5544669, createdName=Amy啊, createdTime=Sun Jul 11 20:59:23 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998576, encodeId=9b009985e622, content=一代豪杰!如此年龄,仍然在一线工作,这几年准备将事业逐步交给儿子和女儿!企业家真心不易呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 11 20:07:34 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998577, encodeId=c74c9985e74f, content=医药领域一周大事频发,扬子江,恒瑞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 11 20:07:44 CST 2021, time=2021-07-11, status=1, ipAttribution=)]
    2021-07-12 cscs

    悼念

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1969196, encodeId=75c1196919663, content=<a href='/topic/show?id=af99882909c' target=_blank style='color:#2F92EE;'>#董事长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88290, encryptionId=af99882909c, topicName=董事长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Jan 24 12:41:06 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495321, encodeId=bf2c1495321c7, content=<a href='/topic/show?id=2b045310288' target=_blank style='color:#2F92EE;'>#悼念#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53102, encryptionId=2b045310288, topicName=悼念)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7da9165163, createdName=zhangfenasdf, createdTime=Tue Jul 13 10:41:06 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998758, encodeId=60ec998e582c, content=悼念, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201208/af76c3dece7248f2b297751d57470291/d45c15338e034c3f847da0bca70bfa4d.jpg, createdBy=3cfe1656094, createdName=cscs, createdTime=Mon Jul 12 11:39:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998748, encodeId=44f1998e48e0, content=🙏🙏🙏, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Mon Jul 12 11:24:18 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998588, encodeId=5ec89985885e, content=悼念, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9c5544669, createdName=Amy啊, createdTime=Sun Jul 11 20:59:23 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998576, encodeId=9b009985e622, content=一代豪杰!如此年龄,仍然在一线工作,这几年准备将事业逐步交给儿子和女儿!企业家真心不易呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 11 20:07:34 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998577, encodeId=c74c9985e74f, content=医药领域一周大事频发,扬子江,恒瑞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 11 20:07:44 CST 2021, time=2021-07-11, status=1, ipAttribution=)]
    2021-07-12 weigq

    🙏🙏🙏

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1969196, encodeId=75c1196919663, content=<a href='/topic/show?id=af99882909c' target=_blank style='color:#2F92EE;'>#董事长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88290, encryptionId=af99882909c, topicName=董事长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Jan 24 12:41:06 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495321, encodeId=bf2c1495321c7, content=<a href='/topic/show?id=2b045310288' target=_blank style='color:#2F92EE;'>#悼念#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53102, encryptionId=2b045310288, topicName=悼念)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7da9165163, createdName=zhangfenasdf, createdTime=Tue Jul 13 10:41:06 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998758, encodeId=60ec998e582c, content=悼念, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201208/af76c3dece7248f2b297751d57470291/d45c15338e034c3f847da0bca70bfa4d.jpg, createdBy=3cfe1656094, createdName=cscs, createdTime=Mon Jul 12 11:39:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998748, encodeId=44f1998e48e0, content=🙏🙏🙏, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Mon Jul 12 11:24:18 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998588, encodeId=5ec89985885e, content=悼念, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9c5544669, createdName=Amy啊, createdTime=Sun Jul 11 20:59:23 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998576, encodeId=9b009985e622, content=一代豪杰!如此年龄,仍然在一线工作,这几年准备将事业逐步交给儿子和女儿!企业家真心不易呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 11 20:07:34 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998577, encodeId=c74c9985e74f, content=医药领域一周大事频发,扬子江,恒瑞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 11 20:07:44 CST 2021, time=2021-07-11, status=1, ipAttribution=)]
    2021-07-11 Amy啊

    悼念

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1969196, encodeId=75c1196919663, content=<a href='/topic/show?id=af99882909c' target=_blank style='color:#2F92EE;'>#董事长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88290, encryptionId=af99882909c, topicName=董事长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Jan 24 12:41:06 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495321, encodeId=bf2c1495321c7, content=<a href='/topic/show?id=2b045310288' target=_blank style='color:#2F92EE;'>#悼念#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53102, encryptionId=2b045310288, topicName=悼念)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7da9165163, createdName=zhangfenasdf, createdTime=Tue Jul 13 10:41:06 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998758, encodeId=60ec998e582c, content=悼念, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201208/af76c3dece7248f2b297751d57470291/d45c15338e034c3f847da0bca70bfa4d.jpg, createdBy=3cfe1656094, createdName=cscs, createdTime=Mon Jul 12 11:39:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998748, encodeId=44f1998e48e0, content=🙏🙏🙏, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Mon Jul 12 11:24:18 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998588, encodeId=5ec89985885e, content=悼念, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9c5544669, createdName=Amy啊, createdTime=Sun Jul 11 20:59:23 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998576, encodeId=9b009985e622, content=一代豪杰!如此年龄,仍然在一线工作,这几年准备将事业逐步交给儿子和女儿!企业家真心不易呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 11 20:07:34 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998577, encodeId=c74c9985e74f, content=医药领域一周大事频发,扬子江,恒瑞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 11 20:07:44 CST 2021, time=2021-07-11, status=1, ipAttribution=)]
    2021-07-11 lovetcm

    一代豪杰!如此年龄,仍然在一线工作,这几年准备将事业逐步交给儿子和女儿!企业家真心不易呀

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1969196, encodeId=75c1196919663, content=<a href='/topic/show?id=af99882909c' target=_blank style='color:#2F92EE;'>#董事长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88290, encryptionId=af99882909c, topicName=董事长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Jan 24 12:41:06 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495321, encodeId=bf2c1495321c7, content=<a href='/topic/show?id=2b045310288' target=_blank style='color:#2F92EE;'>#悼念#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53102, encryptionId=2b045310288, topicName=悼念)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7da9165163, createdName=zhangfenasdf, createdTime=Tue Jul 13 10:41:06 CST 2021, time=2021-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998758, encodeId=60ec998e582c, content=悼念, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201208/af76c3dece7248f2b297751d57470291/d45c15338e034c3f847da0bca70bfa4d.jpg, createdBy=3cfe1656094, createdName=cscs, createdTime=Mon Jul 12 11:39:56 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998748, encodeId=44f1998e48e0, content=🙏🙏🙏, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Mon Jul 12 11:24:18 CST 2021, time=2021-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998588, encodeId=5ec89985885e, content=悼念, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d9c5544669, createdName=Amy啊, createdTime=Sun Jul 11 20:59:23 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998576, encodeId=9b009985e622, content=一代豪杰!如此年龄,仍然在一线工作,这几年准备将事业逐步交给儿子和女儿!企业家真心不易呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 11 20:07:34 CST 2021, time=2021-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998577, encodeId=c74c9985e74f, content=医药领域一周大事频发,扬子江,恒瑞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 11 20:07:44 CST 2021, time=2021-07-11, status=1, ipAttribution=)]
    2021-07-11 lovetcm

    医药领域一周大事频发,扬子江,恒瑞!

    0